Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
9,816,725
-
Share change
-
-1,669,182
-
Total reported value
-
$30,235,236
-
Put/Call ratio
-
280%
-
Price per share
-
$3.08
-
Number of holders
-
33
-
Value change
-
-$3,425,688
-
Number of buys
-
12
-
Number of sells
-
11
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q4 2023
As of 31 Dec 2023,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,816,725 shares.
The largest 10 holders included
Long Focus Capital Management, LLC, Capital International Investors, CREDIT SUISSE AG/, BAILLIE GIFFORD & CO, PRINCIPAL FINANCIAL GROUP INC, MACQUARIE GROUP LTD, KBC Group NV, OPPENHEIMER & CO INC, MORGAN STANLEY, and LPL Financial LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.